Clinical Leader Expands Editorial Advisory Board
By Ed Miseta, Chief Editor, Clinical Leader
Erie, PA – Clinical Leader, the pharmaceutical industry’s leading online resource for clinical trial analysis and opinion, is dedicated to streamlining the clinical research process by connecting trial sponsors with cutting edge service providers to speed medicines to patients. Our goal is to facilitate connections and improve collaborations by providing valuable information on CROs, sponsors, and advancements in clinical trials.
To ensure readers receive content that is timely and valuable, Clinical Leader relies on the feedback of pharma industry professionals and consultants to guide its focus and direction. The editorial advisory board, composed of consultants and executives from the pharmaceutical industry, helps guide the direction and focus of the site’s editorial content.
Clinical Leader is proud to announce that in 2015, seventeen distinguished industry executives were added to the board:
Beverly Harrison, Senior Director, Patient Support, Janssen Pharmaceutical Companies of Johnson & Johnson
Angie Maurer, RN, BSN, MBA, Principal, Maurer Consulting LLC.
Andrew Dahlem, VP, COO, Lilly Research Laboratories, Eli Lilly and Company
James J. Gillespie, CEO, Center for Healthcare Innovation
Abbe Steel, Founder and CEO, HealthiVibe, LLC.
Danya Burakoff, Senior Manager, Business Development & Client Engagement, The Avoca Group
Tina Shah, Physician and Health Services Researcher, Pulmonary and Critical Care, University of Chicago
John Lewis, Senior Vice President, Policy & Public Affairs, Assoc. of Clinical Research Organizations
Roslyn Schneider, Global Patient Affairs Lead, Pfizer Medical at Pfizer
Stephanie Petrone, Executive Director, Medical Operations, Novartis
Michael McKay, Associate Director, Operational Excellence, Shire Pharmaceuticals
Michael Harte, Founder & President, Harte Group
Dennis Earle, Director, Operational Portfolio Lead, Oncology, Bristol-Myers Squibb
Jeremy Gilbert, VP of Product and Strategy, PatientsLikeMe
Peter Schiemann, Managing Partner, Widler & Schiemann Ltd.
George Betts, Executive Director, Medical Affairs, Regeneron Pharmaceuticals
Anne White, VP, Portfolio Management, Eli Lilly and Company
The inaugural Clinical Leader editorial advisory board was launched in December 2014. The new members will join the following individuals, who were all a part of that initial board:
Lori Abrams, Director, Advocacy Diversity & Patient Engagement, Global Development Operations, Bristol-Myers Squibb
Moe Alsumidaie, President and Chief Scientific Officer, Annex Clinical
Glen Andrews, Asset Team Leader, Inlyta, Sutent, & Torisel, Pfizer Oncology
Suzanne Besaw, Senior Manager, Global Sourcing Alliance Management, R&D Sourcing/Procurement, Bayer HealthCare
Deirdre Bevard, VP Development Operations, Nektar Therapeutics
Trish Childers, Sourcing Manager, Research Procurement, Merck
Peter Covitz, Senior Director, Information Strategy & Analytics, Pfizer
Gregory J. Fiore, MD, Chief Medical Officer and Founder, SSI Strategy; President Fiore Healthcare Advisors LLC
Rashmi Gandhi, Director of Business Operations, Early Development and Translational Oncology Group, Pfizer Global R&D
Pam Garzone, Executive Director, Biotechnology and Clinical Development, Pfizer WRD
John P. Hall, President, Shore Research & Development
Michael Martorelli, Director, Fairmount Partners
Kirsten Morasco, President, KLM Consulting
Christine Pierre, Founder and President, Society for Clinical Research Sites
Johann Proeve, VP Global Strategy & Development Advisor, Bayer HealthCare
Charles Romano, Senior Director of Clinical Research, TissueTech, Inc.
Steven Sweeney, VP Clinical Development Operations, Annovation Biopharma
Craig Wozniak, Head, Americas Clinical Operations, GSK
Michael W. Young, Principal, biomedwoRx Life Sciences Consulting
Clinical Leader thanks all of these professionals for agreeing to serve and looks forward to working with all of these individuals to ensure published articles continue to provide readers with actionable information that will help make their companies and clinical trials more successful.
The entire editorial advisory board can be seen here.
For more information:
Ed Miseta, Chief Editor
(814) 897-7700 ext. 179
ed.miseta@lifescienceconnect.com